JP2018518486A5 - - Google Patents

Download PDF

Info

Publication number
JP2018518486A5
JP2018518486A5 JP2017563541A JP2017563541A JP2018518486A5 JP 2018518486 A5 JP2018518486 A5 JP 2018518486A5 JP 2017563541 A JP2017563541 A JP 2017563541A JP 2017563541 A JP2017563541 A JP 2017563541A JP 2018518486 A5 JP2018518486 A5 JP 2018518486A5
Authority
JP
Japan
Prior art keywords
compound
obtaining
reacted
give
give compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017563541A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018518486A (ja
JP6873053B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/036434 external-priority patent/WO2016200930A1/en
Publication of JP2018518486A publication Critical patent/JP2018518486A/ja
Publication of JP2018518486A5 publication Critical patent/JP2018518486A5/ja
Application granted granted Critical
Publication of JP6873053B2 publication Critical patent/JP6873053B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017563541A 2015-06-08 2016-06-08 タンパク質脱アセチル化阻害剤の製造方法 Active JP6873053B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562172624P 2015-06-08 2015-06-08
US62/172,624 2015-06-08
PCT/US2016/036434 WO2016200930A1 (en) 2015-06-08 2016-06-08 Methods of making protein deacetylase inhibitors

Publications (3)

Publication Number Publication Date
JP2018518486A JP2018518486A (ja) 2018-07-12
JP2018518486A5 true JP2018518486A5 (cg-RX-API-DMAC7.html) 2019-07-04
JP6873053B2 JP6873053B2 (ja) 2021-05-19

Family

ID=56264043

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017563541A Active JP6873053B2 (ja) 2015-06-08 2016-06-08 タンパク質脱アセチル化阻害剤の製造方法

Country Status (11)

Country Link
US (1) US10144714B2 (cg-RX-API-DMAC7.html)
EP (1) EP3303304B1 (cg-RX-API-DMAC7.html)
JP (1) JP6873053B2 (cg-RX-API-DMAC7.html)
CN (1) CN107922352B (cg-RX-API-DMAC7.html)
AR (1) AR105812A1 (cg-RX-API-DMAC7.html)
AU (2) AU2016276573A1 (cg-RX-API-DMAC7.html)
CA (1) CA2988594C (cg-RX-API-DMAC7.html)
ES (1) ES2769255T3 (cg-RX-API-DMAC7.html)
MX (1) MX369349B (cg-RX-API-DMAC7.html)
TW (1) TWI706937B (cg-RX-API-DMAC7.html)
WO (1) WO2016200930A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2526093T3 (pl) * 2010-01-22 2017-02-28 Acetylon Pharmaceuticals, Inc. Odwrócone związki amidowe jako inhibitory deacetylazy białkowej oraz sposoby ich stosowania
EP2839037B1 (en) 2012-04-19 2018-12-26 Acetylon Pharmaceuticals, Inc. Biomarkers to identify patients that will respond to treatment and treating such patients
TW201718516A (zh) 2015-06-08 2017-06-01 艾斯特隆製藥公司 組蛋白去乙醯酶抑制劑之晶形
AU2016276573A1 (en) 2015-06-08 2018-01-04 Acetylon Pharmaceuticals, Inc. Methods of making protein deacetylase inhibitors
WO2017214565A1 (en) * 2016-06-09 2017-12-14 Dana-Farber Cancer Institute, Inc., Methods of use and pharmaceutical combinations of hdac inhibitors with bet inhibitors
EP3496751B1 (en) 2016-08-08 2022-10-19 Acetylon Pharmaceuticals Inc. Pharmaceutical combinations of histone deacetylase 6 inhibitors and cd20 inhibitory antibodies and uses thereof
JP7090611B2 (ja) 2016-11-23 2022-06-24 アセチロン ファーマシューティカルズ インコーポレイテッド ヒストン脱アセチル化酵素阻害剤とプログラム細胞死リガンド1(pd-l1)阻害剤とを含む医薬組み合わせ物及びその使用方法

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
DE60143520D1 (de) 2000-03-24 2011-01-05 Methylgene Inc Inhibitoren der histon-deacetylase
JPWO2002074298A1 (ja) 2001-03-21 2004-07-08 小野薬品工業株式会社 Il−6産生阻害剤
US7244853B2 (en) 2001-05-09 2007-07-17 President And Fellows Of Harvard College Dioxanes and uses thereof
DK1442019T3 (da) 2001-11-01 2008-01-14 Janssen Pharmaceutica Nv Amidderivater som glycogensynthasekinase 3- beta-inhibitorer
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7375228B2 (en) 2003-03-17 2008-05-20 Takeda San Diego, Inc. Histone deacetylase inhibitors
WO2005007091A2 (en) 2003-07-07 2005-01-27 Georgetown University Histone deacetylase inhibitors and methods of use thereof
CA2561617A1 (en) 2004-04-05 2005-10-20 Aton Pharma, Inc. Histone deacetylase inhibitor prodrugs
AU2006226861B2 (en) 2005-03-22 2012-08-16 Dana-Farber Cancer Institute, Inc. Treatment of protein degradation disorders
KR20080052611A (ko) 2005-08-26 2008-06-11 메틸진 인크. 히스톤 탈아세틸 효소의 벤조디아제핀 및 벤조피페라진유도체 억제제
JP5441416B2 (ja) 2006-02-14 2014-03-12 プレジデント アンド フェロウズ オブ ハーバード カレッジ 二官能性ヒストンデアセチラーゼインヒビター
WO2007130429A2 (en) 2006-05-03 2007-11-15 The President And Fellows Of Harvard College Histone deacetylase and tubulin deacetylase inhibitors
WO2007144341A1 (en) 2006-06-12 2007-12-21 Vrije Universiteit Brussel Differentiation of rat liver epithelial cells into hepatocyte-like cells
ES2288802B1 (es) 2006-07-07 2008-12-16 Universidad De Granada Nuevos derivados de ftalimida como inhibidores de las histonas desacetilasas.
AU2007296743B2 (en) 2006-09-11 2012-02-16 Curis, Inc. Tyrosine kinase inhibitors containing a zinc binding moiety
CN101951930A (zh) 2008-02-19 2011-01-19 阿奈斯特药品株式会社 对身体功能的恢复有用的口服或经肠组合物
AU2009274549B2 (en) 2008-07-23 2014-05-01 Dana-Farber Cancer Institute, Inc. Deacetylase inhibitors and uses thereof
EP2429987A4 (en) 2009-05-15 2012-10-03 Korea Res Inst Chem Tech AMIDE COMPOUND, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
WO2011019393A2 (en) 2009-08-11 2011-02-17 President And Fellows Of Harvard College Class- and isoform-specific hdac inhibitors and uses thereof
MA33926B1 (fr) * 2009-12-17 2013-01-02 Merck Sharp & Dohme Aminopyrimidines en tant qu'inhibiteurs de la syk
WO2011084991A2 (en) 2010-01-08 2011-07-14 President And Fellows Of Harvard College Fluorinated hdac inhibitors and uses thereof
PL2526093T3 (pl) * 2010-01-22 2017-02-28 Acetylon Pharmaceuticals, Inc. Odwrócone związki amidowe jako inhibitory deacetylazy białkowej oraz sposoby ich stosowania
EP2571352A4 (en) 2010-05-21 2014-09-17 Sloan Kettering Inst Cancer SELECTIVE HDAC HEMMER
WO2012018499A2 (en) 2010-08-05 2012-02-09 Acetylon Pharmaceuticals Specific regulation of cytokine levels by hdac6 inhibitors
ES2568260T3 (es) 2010-11-16 2016-04-28 Acetylon Pharmaceuticals, Inc. Compuestos de pirimidin hidroxi amida como inhibidores de proteína desacetilasa y métodos de uso de los mismos
US9512083B2 (en) 2011-07-20 2016-12-06 The General Hospital Corporation Histone deacetylase 6 selective inhibitors for the treatment of bone disease
WO2013048949A2 (en) 2011-09-26 2013-04-04 Bristol-Myers Squibb Company Selective nr2b antagonists
JP5724851B2 (ja) * 2011-11-30 2015-05-27 東レ株式会社 N−(ヨードフェニル)ピリミジニルアミン誘導体の製造方法
EP2839037B1 (en) 2012-04-19 2018-12-26 Acetylon Pharmaceuticals, Inc. Biomarkers to identify patients that will respond to treatment and treating such patients
JP2015533173A (ja) 2012-10-12 2015-11-19 トラスティース・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア タンパク質脱アセチル化酵素阻害剤としてのピリミジンヒドロキシアミド化合物およびその使用方法
US9145412B2 (en) 2012-11-02 2015-09-29 Acetylon Pharmaceuticals, Inc. Selective HDAC1 and HDAC2 inhibitors
EP2951153B1 (en) 2013-02-01 2019-04-03 Regenacy Pharmaceuticals, LLC Selective hdac3 inhibitors
US9139583B2 (en) 2013-02-01 2015-09-22 Acetylon Pharmaceuticals, Inc. Selective HDAC3 inhibitors
US20140357512A1 (en) 2013-06-03 2014-12-04 Acetylon Pharmaceuticals, Inc. Histone deacetylase (hdac) biomarkers in multiple myeloma
EP3046559A4 (en) 2013-09-20 2017-03-22 Acetylon Pharmaceuticals, Inc. Treatment of diseases caused by abnormal lymphocyte function with an hdac6 inhibitor
JP6626437B2 (ja) 2013-10-08 2019-12-25 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. ヒストンデアセチラーゼ阻害剤とHer2阻害剤またはPI3K阻害剤のいずれかの組み合わせ
US20150105409A1 (en) 2013-10-10 2015-04-16 Acetylon Pharmaceticals, Inc. Hdac inhibitors, alone or in combination with btk inhibitors, for treating nonhodgkin's lymphoma
JP6584391B2 (ja) 2013-10-10 2019-10-02 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. 非ホジキンリンパ腫を治療するための、hdac阻害剤単独またはpi3k阻害剤との組み合わせ
ES2862126T3 (es) 2013-10-10 2021-10-07 Acetylon Pharmaceuticals Inc Compuestos de pirimidín-hidroxiamida como inhibidores de histona desacetilasa
EA201690753A1 (ru) 2013-10-11 2016-07-29 Эситайлон Фармасьютикалз, Инк. Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств
EP3060217B1 (en) 2013-10-24 2022-06-08 Mayo Foundation for Medical Education and Research Treatment of polycystic diseases with an hdac6 inhibitor
US9949972B2 (en) 2013-12-03 2018-04-24 Acetylon Pharmaceuticals, Inc Combinations of histone deacetylase inhibitors and immunomodulatory drugs
US20150176076A1 (en) 2013-12-20 2015-06-25 Acetylon Pharmaceuticals, Inc. Histone deacetylase 6 (hdac6) biomarkers in multiple myeloma
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
US20150359794A1 (en) 2014-06-13 2015-12-17 Buck Institute For Research On Aging Impairment of the large ribosomal subunit protein rpl24 by depletion or acetylation
CN107205988A (zh) 2014-07-07 2017-09-26 埃斯泰隆制药公司 利用组蛋白脱乙酰酶抑制剂治疗白血病
US20160137630A1 (en) 2014-10-08 2016-05-19 Acetylon Pharmaceuticals, Inc. Induction of gata2 by hdac1 and hdac2 inhibitors
US9937174B2 (en) 2014-12-05 2018-04-10 University of Modena and Reggio Emilia Combinations of histone deacetylase inhibitors and bendamustine
WO2016090230A1 (en) 2014-12-05 2016-06-09 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds for treating peripheral neuropathy
BR112017012504A2 (pt) 2014-12-12 2018-01-09 Acetylon Pharmaceuticals, Inc. derivados de piperidina como inibidores de hdac1/2
WO2016168647A1 (en) 2015-04-17 2016-10-20 Acetylon Pharmaceuticals Inc. Treatment of neuroblastoma with histone deacetylase inhibotrs
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
AU2016276573A1 (en) 2015-06-08 2018-01-04 Acetylon Pharmaceuticals, Inc. Methods of making protein deacetylase inhibitors
TW201718516A (zh) 2015-06-08 2017-06-01 艾斯特隆製藥公司 組蛋白去乙醯酶抑制劑之晶形
EP3496751B1 (en) 2016-08-08 2022-10-19 Acetylon Pharmaceuticals Inc. Pharmaceutical combinations of histone deacetylase 6 inhibitors and cd20 inhibitory antibodies and uses thereof

Similar Documents

Publication Publication Date Title
JP2018518486A5 (cg-RX-API-DMAC7.html)
JP2013505259A5 (cg-RX-API-DMAC7.html)
RU2016110024A (ru) Некоторые химические соединения, композиции и способы
JP2018193405A5 (cg-RX-API-DMAC7.html)
JP2009527517A5 (cg-RX-API-DMAC7.html)
JP2017505801A5 (cg-RX-API-DMAC7.html)
JP2008523069A5 (cg-RX-API-DMAC7.html)
RU2016133187A (ru) Способ получения n-[(3-аминооксетан-3-ил)метил]-2-(1,1-диоксо-3,5-дигидро-1,4-бензотиазепин-4ил)-6-метил-хиназолин-4-амина
JP2005525427A5 (cg-RX-API-DMAC7.html)
JP2015518821A5 (cg-RX-API-DMAC7.html)
JP2016188255A5 (cg-RX-API-DMAC7.html)
JP2018524387A5 (cg-RX-API-DMAC7.html)
CN1875006A (zh) 氟甲基取代的杂环的制备方法
JP2018507858A5 (cg-RX-API-DMAC7.html)
JP2008540414A5 (cg-RX-API-DMAC7.html)
JP2019508387A5 (cg-RX-API-DMAC7.html)
JP2022116171A5 (cg-RX-API-DMAC7.html)
RU2012139082A (ru) Способы получения производных циклопропиламида и связанных с ними промежуточных соединений
TWI751203B (zh) 製備經環丙基取代之苯乙酮的方法
JP2018009003A5 (cg-RX-API-DMAC7.html)
JP7232618B2 (ja) アコチアミドの改善された製造方法
JP2018536654A5 (cg-RX-API-DMAC7.html)
JP6903119B2 (ja) m−ジアミド化合物の臭素化方法
BR112020004825B1 (pt) Processo aperfeiçoado para a preparação de trifloxistrobina
JP2015535210A5 (cg-RX-API-DMAC7.html)